Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-07 · accession 0001439222-24-000140 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-12 | 2024-11-07 | AGIO | Burns James William | CLO | S - Sale | $52.21 | -21.8K | 15.7K | -58% | -$1.14M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-11-07 | S | D | 13,411 | $52.00 | 24,041 | D | — | — | (F2) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $51.33 to $52.32. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. (F3) Includes 3,091 shares purchased through the Company's employee stock purchase plan. |
| 2 | Common | Common stock | 2024-11-07 | S | D | 8,341 | $52.56 | 15,700 | D | — | — | (F4) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $52.33 to $52.88. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |